Evidence map›Paper›PMID 32271150›Full record

ArticleJournal of medical Internet research2020

Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences.

Lærke K Tolstrup, Helle Pappot, Lars Bastholt, Ann-Dorthe Zwisler, Karin B Dieperink

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03073031 (The Use of PRO-CTCAE by Patients Receiving Immunotherapy for the Treatment of Malignant Melanoma), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03073031 nacompletednot on this map

The Use of PRO-CTCAE by Patients Receiving Immunotherapy for the Treatment of Malignant Melanoma

TypeinterventionalSponsorOdense University HospitalRan2017 to 2019Enrolled146ConditionsAdverse EffectsArmsTablet: Samsung Galaxy Tab A
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Can electronic assessment tools improve the process of shared decision-making? A systematic review.Health information management : journal of the Health Information Management Association of Australia · 2023
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Exploring the lived experiences of women with metastatic breast cancer and their HRQoL questionnaire preferences: a qualitative study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lærke K Tolstrup *Department of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-9554-5385
Helle Pappot *Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0002-3570-5372
Lars Bastholt *Department of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID 0000-0001-5478-9826
Ann-Dorthe Zwisler *Department of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-9241-2090
Karin B Dieperink *Department of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID 0000-0003-4766-3242
University of Southern Denmark · DKCopenhagen University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting of side effects and the derived communication.

objectiveThe primary objective of this study was to examine patients' and clinicians' experiences with an eHealth intervention for weekly monitoring of side effects during treatment with immunotherapy.

methodsAn eHealth intervention based on questions from the PRO-Common Terminology Criteria for Adverse Events (CTCAE) library was used and tested in a randomized clinical trial with patients receiving immunotherapy for malignant melanoma and clinicians at a university hospital in Denmark. On a weekly basis, patients reported their symptoms from home during the treatment via a provided tablet. The electronic patient reports were available to clinicians in the outpatient clinic. A mixed methods approach was applied to investigate the patients' and clinicians' experiences with the intervention. Data from patient experiences were collected in a short survey, the Patient Feedback Form. Moreover, a subset of the patients participating in the survey was interviewed about their experience. Furthermore, one focus group interview with clinicians was carried out to elucidate their views.

resultsA total of 57 patients completed the Patient Feedback Form, and 14 patients were interviewed. The focus group interview included 5 clinicians. Overall, patients and clinicians were satisfied with the tool. They believed it enhanced patients' awareness of side effects and increased their feeling of involvement. The patients reported that it was easy to fill out the questionnaire and that it made sense to do so. However, a minority of the patients expressed in the interviews that they did not believe that the health care professionals had seen their reports when they came to the clinic, and that the reporting did not lead to increased contact with the department.

conclusionsOverall, satisfaction with the eHealth intervention was high among patients and their treating clinicians. The tool was easy to use and contributed to greater symptom awareness and patient involvement. Thus, in terms of patient and clinician satisfaction with the tool, it makes sense to continue using the tool beyond the project period.

trial registrationClinicalTrials.gov NCT03073031; https://tinyurl.com/tjx3gtu.

Indexed as

Patient Reported Outcome MeasuresAgedFemaleHumansImmunotherapyMaleMelanomaSurveys and QuestionnairesTelemedicineCPIs, interviewsside effects, adverse events, patient-reported outcomes, PRO-CTCAE, melanoma, eHealth, immunotherapy, patient satisfaction

Identifiers

PMID32271150
PMCPMC7180512
OpenAlexW3002564544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.